Jon Merlin Selected Research

Jon Merlin Research Topics

3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2019
3	Obesity 01/2022 - 10/2020
2	Inflammation (Inflammations) 01/2022 - 11/2021
1	Systemic Scleroderma (Systemic Sclerosis) 01/2022
1	Rheumatoid Arthritis 01/2022
1	Insulin Resistance 11/2021
1	Bradycardia 01/2021
1	Heart Failure 01/2021
1	Metabolic Diseases (Metabolic Disease) 10/2020
1	Overactive Urinary Bladder (Overactive Bladder) 10/2020
1	Ischemia 11/2018
1	Hypoxia (Hypoxemia) 11/2018

3	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 01/2019
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022 - 11/2021
2	Adrenergic Receptors (Adrenergic Receptor)IBA 10/2020 - 11/2018
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2022
1	VCP746IBA 01/2021
1	capadenosonIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2021
1	Adenosine-5'-(N-ethylcarboxamide) (NECA)IBA 01/2021
1	Adenosine A1 ReceptorIBA 01/2021
1	mirabegronIBA 10/2020
1	Insulin (Novolin)FDA Link 01/2019
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 11/2018
1	Dobutamine FDA LinkGeneric 11/2018
1	Dopamine (Intropin)FDA LinkGeneric 11/2018

1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 11/2021
1	Therapeutics 11/2018